Discover
PHAT
Phathom Pharmaceuticals, Inc.
7.25
1 x 7.25
2 x 9.10
bid
ask
+
0.12
1.68%
2 @ 04:01 PM
7.25 +0.00 (0.00%)
| Ytd | -56.30% | |
| 1y | -37.71% |
7.01
day range
7.30
6.70
52 week range
18.08
| Open | 7.13 | Prev Close | 7.13 | Low | 7.01 | High | 7.30 | Mkt Cap | 586.53M |
| Vol | 928.34K | Avg Vol | 1.38M | EPS | -1.26 | P/E | N/A | Forward P/E | 7.60 |
| Beta | 0.61 | Short Ratio | 9.36 | Inst. Own | 83.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 8.33 | 200-d Avg | 11.22 | 1yr Est | 23.70 |
| Income Statement | |||
| Total Revenue | 74.27M | ||
| Revenues (USD) | 74.27M | ||
| Cost of Revenue | 15.10M | ||
| Gross Profit | 59.18M | ||
| Operating Expenses | 63.14M | ||
| Research and Development Expense | 7.81M | ||
| Selling, General and Administrative Expense | 55.33M | ||
| Operating Income | -3.96M | ||
| Interest Expense | 15.10M | ||
| Net Income | -17.58M | ||
| Net Income Common Stock | -17.58M | ||
| Net Income Common Stock (USD) | -17.58M | ||
| Consolidated Income | -17.58M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -2.48M | ||
| Earning Before Interest & Taxes (USD) | -2.48M | ||
| Weighted Average Shares | 83.75M | ||
| Weighted Average Shares Diluted | 83.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 185.34M | ||
| Cash and Equivalents (USD) | 185.34M | ||
| Trade and Non-Trade Receivables | 97.42M | ||
| Current Assets | 295.92M | ||
| Property, Plant & Equipment Net | 3.38M | ||
| Total Assets | 327.08M | ||
| Debt Current | 670.00K | ||
| Total Debt | 514.74M | ||
| Current Liabilities | 153.78M | ||
| Debt Non-Current | 514.07M | ||
| Total Liabilities | 671.35M | ||
| Accumulated Retained Earnings (Deficit) | -1.53B | ||
| Shareholders Equity | -344.27M | ||
| Shareholders Equity (USD) | -344.27M | ||
| Assets Non-Current | 31.16M | ||
| Total Debt (USD) | 514.74M | ||
| Inventory | 29.54M | ||
| Liabilities Non-Current | 517.57M | ||
| Trade and Non-Trade Payables | 5.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 114.00K | ||
| Net Cash Flow from Financing | 3.55M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.58M | ||
| Capital Expenditure | -44.00K | ||
| Issuance (Purchase) of Equity Shares | 3.55M | ||
| Net Cash Flow from Investing | -44.00K | ||
| Net Cash Flow from Operations | -1.93M | ||
| Share Based Compensation | 6.71M | ||